Want to join the conversation?
$ICUI agreed to buy all of $PFE's global infusion therapy business, Hospira Infusion Systems (HIS), for $1Bil in cash and stock. $PFE will receive about $400MM in newly issued common shares of $ICUI and $600MM in cash. The companies expect to close the transaction in 1Q17.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.